Covid-19 breath test startup Breathonix raising US$5m capital
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
BREATHONIX, a Singapore-based startup which has gotten provisional authorisation locally for its Covid-19 breath test, is raising US$5 million in Series A funding to fuel its growth.
"At this stage now, we are growing very fast. We're expanding our team for commercialisation, so we're actively raising more funds," co-founder and chief operating officer Du Fang said during a Monday virtual press conference.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
StarHub hands Ensign InfoSecurity control back to Temasek in S$115 million deal, books S$200 million gain
Singaporeans can now buy record amount of yen per Singdollar
Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss
Keppel DC Reit posts 13.2% higher Q1 DPU of S$0.02833 on strong portfolio performance
